| Literature DB >> 25493676 |
Mariana Cristina Augusto1, Maria José Trevizani Nitsche2, Cristina Maria Garcia de Lima Parada3, Maria Lúcia Zanetti4, Maria Antonieta de Barros Leite Carvalhaes2.
Abstract
OBJECTIVE: To evaluate the structure, process and results of the Capillary Blood Glucose Self-monitoring Program in a Brazilian city.Entities:
Mesh:
Year: 2014 PMID: 25493676 PMCID: PMC4292667 DOI: 10.1590/0104-1169.3282.2483
Source DB: PubMed Journal: Rev Lat Am Enfermagem ISSN: 0104-1169
Figure 1- Structure, process and outcome variables used in PAMGC assessment, Botucatu, 2010.
- Structure indicators for the health professionals working in the Distribution Program of Glucometers and Inputs for Self-Monitoring of Capillary Glucose, Botucatu, SP, Brazil, 2010.
| Structure indicators | Profissionals (N=96) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Physicians | Nurses | Secondary level | Total | p* | |||||||||
| N | % | N | % | N | % | N | % | ||||||
| Preliminary training | 0,717 | ||||||||||||
| Yes | 1 | 4,8 | 2 | 10,5 | 6 | 10,7 | 9 | 9,4 | |||||
| No | 20 | 95,2 | 17 | 89,5 | 50 | 89,3 | 87 | 90,6 | |||||
| Knowledge of registration criteria | 0,719 | ||||||||||||
| All criteria | - | - | - | - | - | - | - | 0 | |||||
| Only one criterion | 17 | 81 | 17 | 89,5 | 46 | 82,1 | 80 | 83,3 | |||||
| Does not know criteria | 4 | 19 | 2 | 10,5 | 10 | 17,9 | 16 | 16,7 | |||||
| Frequency of daily capillary glucose verification | <0,0001 | ||||||||||||
| Yes | 4 | 19 | - | - | - | - | 4 | 4,2 | |||||
| No | 17 | 81 | 19 | 100 | 56 | 100 | 92 | 95,8 | |||||
P-value, chi-square test
- Structure indicators for patients registered in the Distribution Program of Glucometers and Inputs for Self- Monitoring of Capillary Glucose, Botucatu, SP, Brazil, 2010.
| Structure indicators | Pacients | ||
|---|---|---|---|
| N | % | ||
| Orientations when registering in PAMGC | |||
| Yes | 253 | 87,8 | |
| No | 35 | 12,2 | |
| Orientations about technical aspects of measuring | |||
| Calibration. storage of strips. puncture site. amount of blood. use of substances that can interfere in the method | 11 | 3,8 | |
| Received between two and four correct orientations | 50 | 17,4 | |
| Received one correct orientation | 144 | 50,0 | |
| Received incorrect orientations or does not recall the orientations | 83 | 28,8 | |
| Orientations about frequency of capillary glucose verifications | |||
| Yes | 247 | 85,8 | |
| No | 41 | 14,2 | |
| Orientations about frequency of capillary glucose verifications | |||
| Follow Ministry of Health recommendations | 231 | 80,2 | |
| Differ from Ministry of Health indications or did not receive orientations | 57 | 19,8 | |
| Orientations about glucose control parameters | |||
| Yes | 186 | 65,6 | |
| No | 102 | 35,4 | |
| Orientations about capillary glucose parameters | |||
| Know correct fasting. mean and post-prandial glucose levels | 9 | 3,1 | |
| Know correct values of one or two glucose control parameters | 154 | 53,5 | |
| Indicate incorrect values for two or more parameters | 23 | 8,0 | |
| Patient did not receive orientation | 102 | 35,4 | |
- Process indicators for professionals working in the Distribution Program of Glucometers and Inputs for Self- Monitoring of Capillary Glucose, Botucatu, SP, Brazil, 2010.
| Process indicators | Profissionals | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Physicians (N=21) | Nurses | Auxiliaries and technicians (N=56) | Total (N=96) | P | ||||||
| N | % | N | % | N | % | N | % | |||
| Advises the patient to modify insulin doses (N=21) | ||||||||||
| Yes | 6 | 28,6 | ||||||||
| No | 15 | 71,4 | 0,421 | |||||||
| Diet, weight loss and physical exercise | ||||||||||
| Diet, weight loss, physical exercise and smoking cessation | 2 | 9,5 | 2 | 10,5 | 1 | 1,7 | 5 | 5,2 | ||
| Diet, weight loss and physical exercise | 13 | 61,9 | 10 | 52,6 | 28 | 50,0 | 51 | 53,1 | ||
| Diet and weight loss | 4 | 19,0 | 6 | 31,6 | 23 | 41,1 | 33 | 34,4 | ||
| No lifestyle orientation | 2 | 9,5 | 1 | 5,30 | 4 | 7,2 | 7 | 7,3 | ||
| Requests and verifies glucose controls during consultations (N=40) | ||||||||||
| Yes | 21 | 100 | 19 | 100 | ||||||
| No | - | - | - | - | 0,034 | |||||
| Requests recommended tests (N=40) | ||||||||||
| All (fasting glucose, lipid profile, glycated hemoglobin, urea and creatinine) | 6 | 28,6 | 12 | 63,1 | 18 | 45,0 | ||||
| Requests at least glycated hemoglobin and fasting glucose | 15 | 71,4 | 6 | 31,6 | 21 | 52,5 | ||||
| Does not request minimal tests (glycated hemoglobin and fasting glucose) | - | 1 | 5,3 | 1 | 2,5 | 0,016 | ||||
| Knows levels and uses glycated hemoglobin for conducts (N=40) | ||||||||||
| Yes | 4 | 19,1 | 1 | 5,2 | 5 | 12,5 | ||||
| No | 17 | 80,9 | 18 | 94,7 | 35 | 87,5 | 0,647 | |||
| Knows levels and uses fasting glucose for conducts (N=96) | ||||||||||
| Yes | 8 | 38,1 | 8 | 42,1 | 22 | 39,3 | 38 | 39,6 | ||
| No | 13 | 61,9 | 11 | 57,9 | 34 | 60,7 | 58 | 60,4 | ||
| Knows correct values and uses post-prandial glucose (N=96) | 0,671 | |||||||||
| Yes | 3 | 14,3 | 4 | 21,1 | 6 | 10,7 | 13 | 13,5 | ||
| No | 18 | 85,7 | 15 | 78,9 | 50 | 89,3 | 83 | 86,5 | ||
| Knows correct values and uses mean glucose (N=96) | 0,056 | |||||||||
| Yes | 4 | 19,1 | 3 | 15,8 | 2 | 3,6 | 9 | 9,4 | ||
| No | 17 | 80,9 | 16 | 84,2 | 54 | 96,4 | 87 | 90,6 | ||
- Synthesis of structure, process and outcome indicators (in percentages) for the Distribution Program of Glucometers and Inputs for Self-Monitoring of Capillary Glucose, Botucatu, SP, Brasil, 2010
| Indicators | % of professional or patients | |
|---|---|---|
| Structure | ||
| Professionals who know the registration criteria and disease control parameters | - | |
| Process | ||
| Professionals who request capillary glucose levels during consultations, advise on diet, physical exercise and smoking cessation, when relevant, and request glycated hemoglobin, fast glucose and lipid profile, urea and creatinine tests. | 2,5 | |
| Patients who follow recommendations on number of glucose measures | 15,3 | |
| Patients with glycated hemoglobin, fasting glucose and lipid profile, urea and creatinine tests during 12 months before interview date. | 18,0 | |
| Outcome | ||
| Professionals who consider that the PAMGC improved the patients’ disease control | 81,3 | |
| Patients with skills to act on glucose levels | 9,7 | |
| Patients who consider the inclusion in the PAMGC positive for their care and control | 86,4 | |